Galena Biopharma Inc news

   Watch this stock
Showing stories 1 - 10 of about 91   

Articles published

GALE 2.16 -0.03 (-1.37%)
price chart
Why Galena Biopharma, Inc. Stock Crashed By 52% in 2014
The overall market may be on pace to deliver solid gains for investors in 2014, but shareholders in Galena Biopharma (NASDAQ: GALE ) can do nothing but shake their head in disappointment with their stock down 52% for the year.
Related articles »  
Technical Coverage on Biotech Equities - Galena Biopharma, Gilead Sciences ...
On Tuesday, shares in Galena Biopharma Inc. fluctuated between $2.26 and $2.39 before ending the session 2.54% lower at $2.30.
Related articles »  
Short Interest in Galena Biopharma Decreases By 5.0% (GALE)
Galena Biopharma, Inc (NASDAQ:GALE), formerly RXi Pharmaceuticals Corporation, incorporated on April 3, 2006, is a biotechnology company focused on discovering, developing and commercializing therapies addressing unmet medical needs using ...
Related articles »  
Galena Biopharma Doses First Patient in GALE-401 (Anagrelide Controlled ...
Galena Biopharma, Inc. GALE, +0.00% a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major medical needs across the full spectrum of cancer care, today announced the first patient has ...
Galena Biopharma Says Doses First Patient In GALE-401 Phase 2 Clinical Trial  RTT News
Stocks Buzz -Galena Biopharma Inc (NASDAQ:GALE),Vera Bradley, Inc ...  Techsonian (press release)
Related articles »  
Galena Biopharma Stock Rating Reaffirmed by Roth Capital (GALE)
Galena Biopharma Inc logo Roth Capital reissued their buy rating on shares of Galena Biopharma (NASDAQ:GALE) in a research report released on Thursday morning.
Investors Alert: Galena Biopharma (NASDAQ:GALE), Sky-mobi Limited ...  WallStreet Scope
Related articles »  
Galena Biopharma to Present at the Rodman & Renshaw 16th Annual Global ...
Galena Biopharma, Inc. GALE, +0.00% a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major medical needs across the full spectrum of cancer care, today announced that Mark W.
Related articles »  
Biotech News Bundle: Galena Biopharma Inc (GALE), Aegerion ...
Galena Biopharma Inc (NASDAQ:GALE) climbed higher on Wednesday after MLV & Co analyst Vernon T. Bernardino reiterated a Buy rating on the stock.
Related articles »  
Investor's Alert - Clean Energy Fuels Corp (CLNE), Galena Biopharma Inc ...
Birmingham, West Midlands - (TechSonian) - 09/22/2014 - Elitestockpicks.com is a Stock newsletter website that provides free daily alerts on hot Moving stocks.
Stocks in Focus Galena Biopharma (NASDAQ:GALE), American Airlines Group ...
On September 9, Galena Biopharma Inc. (NASDAQ:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major medical needs across the full spectrum of cancer care, announced the ...
Galena Biopharma Short Interest Down 5.0% in August (GALE)
Galena Biopharma, Inc (NASDAQ:GALE), formerly RXi Pharmaceuticals Corporation, incorporated on April 3, 2006, is a biotechnology company focused on discovering, developing and commercializing therapies addressing unmet medical needs using ...